CDC
WASHINGTON - CDC has confirmed the influenza neuraminidase N1 subtype of the U.S. case of human avian influenza A(H5) reported last week by genetic sequencing. Genetic characterization is ongoing and final data will be made publicly available in GenBankexternal icon as soon as available.
Background. A person has tested positive for avian influenza A(H5) virus (H5 bird flu) in the U.S., as reported by Colorado and confirmed by CDC. This case occurred in a person who had direct exposure to poultry and was involved in the culling (depopulating) of poultry with presumptive H5N1 bird flu. The patient reported fatigue for a few days as their only symptom and has since recovered. The patient is being isolated and treated with the influenza antiviral drug oseltamivir.
Click here to learn more.
Source: CDC.gov
Latest from Pest Control Technology
- TAP Showcases Unique EPA-Registered Insulation Solution
- Atticus' Growing Pest Management Product Portfolio
- Bobby Jenkins Named the 2025 Crown Lifetime Achievement Award Recipient
- Abell Pest Control Marks Five Years of ‘12 Days of Giving’
- Built-by-Owner Home? Look for Surprises
- The Pest Rangers Acquires O.C.E. Pest & Termite Control
- The Professional Pest Management Alliance Expands Investor Network
- Big Blue Bug Solutions’ Holiday Lighting Event Sets New Viewership Record
